Clinical Trial Update: Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study of nivolumab and ipilimumab with or without local consolidation therapy in patients with Stage IV non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING